Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trial.
Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA): A phase I clinical trial